U.S. flag

An official website of the United States government

NM_014363.6(SACS):c.7504C>T (p.Arg2502Ter) AND Charlevoix-Saguenay spastic ataxia

Germline classification:
Pathogenic (9 submissions)
Last evaluated:
Nov 14, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000005848.13

Allele description [Variation Report for NM_014363.6(SACS):c.7504C>T (p.Arg2502Ter)]

NM_014363.6(SACS):c.7504C>T (p.Arg2502Ter)

Gene:
SACS:sacsin molecular chaperone [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q12.12
Genomic location:
Preferred name:
NM_014363.6(SACS):c.7504C>T (p.Arg2502Ter)
Other names:
5254C>T
HGVS:
  • NC_000013.11:g.23336372G>A
  • NG_012342.1:g.102331C>T
  • NM_001278055.2:c.7063C>T
  • NM_014363.6:c.7504C>TMANE SELECT
  • NP_001264984.1:p.Arg2355Ter
  • NP_055178.3:p.Arg2502Ter
  • NC_000013.10:g.23910511G>A
  • NM_014363.4:c.7504C>T
  • NM_014363.5:c.7504C>T
  • c.5254C>T
Nucleotide change:
5254C-T
Protein change:
R2355*
Links:
OMIM: 604490.0002; dbSNP: rs281865118
NCBI 1000 Genomes Browser:
rs281865118
Molecular consequence:
  • NM_001278055.2:c.7063C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_014363.6:c.7504C>T - nonsense - [Sequence Ontology: SO:0001587]
Functional consequence:
No function
Observations:
4

Condition(s)

Name:
Charlevoix-Saguenay spastic ataxia (SACS)
Synonyms:
Autosomal recessive spastic ataxia of Charlevoix-Saguenay; Spastic ataxia of Charlevoix-Saguenay; SPASTIC ATAXIA 6, AUTOSOMAL RECESSIVE
Identifiers:
MONDO: MONDO:0010041; MedGen: C1849140; Orphanet: 98; OMIM: 270550

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000026030OMIM
no assertion criteria provided
Pathogenic
(Feb 1, 2000)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV000054638GeneReviews
no classification provided
not providedgermlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

SCV000678155Counsyl
criteria provided, single submitter

(Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015))
Pathogenic
(Sep 3, 2015)
unknownclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link,

SCV000803693Molecular Genetics Laboratory, BC Children's and BC Women's Hospitals
no assertion criteria provided

(ACMG Guidelines, 2015)
Pathogenic
(Oct 25, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001622769Medical Genetics Laboratory, Tarbiat Modares University
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 1, 2020)
inheritedclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002027640Genome-Nilou Lab
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Sep 5, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004210031Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Feb 10, 2023)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004223820Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Nov 14, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link,

SCV005044606PROSPAX: an integrated multimodal progression chart in spastic ataxias, Center for Neurology; Hertie-Institute for Clinical Brain Research
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 1, 2022)
germlineresearch

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes3not providednot providednot providednot providedclinical testing, research
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, literature only
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
Persianinheritedyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

ARSACS.

Vermeer S, van de Warrenburg BP, Kamsteeg EJ, Brais B, Synofzik M.

2003 Dec 9 [updated 2020 Jan 2]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024.

PubMed [citation]
PMID:
20301432

Rapid detection of the sacsin mutations causing autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Mercier J, Prévost C, Engert JC, Bouchard JP, Mathieu J, Richter A.

Genet Test. 2001 Fall;5(3):255-9.

PubMed [citation]
PMID:
11788093
See all PubMed Citations (4)

Details of each submission

From OMIM, SCV000026030.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

Engert et al. (2000) found a C-to-T transition at nucleotide 5254 of the SACS gene in 6 patients with spastic ataxia of the Charlevoix-Saguenay type (ARSACS; 270550) who carried the minor haplotype. The 5254C-T mutation, which predicts the substitution of a stop codon for arginine, was found in compound heterozygous state with the 6594delT mutation (604490.0001).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From GeneReviews, SCV000054638.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Counsyl, SCV000678155.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Molecular Genetics Laboratory, BC Children's and BC Women's Hospitals, SCV000803693.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Medical Genetics Laboratory, Tarbiat Modares University, SCV001622769.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Persian1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1inheritedyesnot providednot providednot provided1not providednot providednot provided

From Genome-Nilou Lab, SCV002027640.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV004210031.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004223820.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: SACS c.7504C>T (p.Arg2502X) results in a premature termination codon, predicted to cause a truncation of the encoded protein, which is a commonly known mechanism for disease. While this variant is not expected to result in nonsense mediated decay, it is predicted to disrupt the last 2,078 amino acids of the protein. Variants downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 2e-05 in 251338 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.7504C>T has been reported in the literature in multiple individuals affected with Autosomal Recessive Spastic Ataxia Of Charlevoix-Saguenay (e.g., Engert_2000). These data indicate that the variant is very likely to be associated with disease. The following publication was ascertained in the context of this evaluation (PMID: 10655055). Seven submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From PROSPAX: an integrated multimodal progression chart in spastic ataxias, Center for Neurology; Hertie-Institute for Clinical Brain Research, SCV005044606.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided3not providednot providedresearch PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided3not providednot providednot provided

Last Updated: Oct 26, 2024